SCHEMBL2793972

SCHEMBL2793972

c1ccc(-c2ccccc2Nc2cccc3ccccc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.60
ALDH1A1 P00352 2/20 0.60
CYP3A4 P08684 2/20 0.60
HSD17B10 Q99714 2/20 0.60
TP53 P04637 1/20 0.60
HPGD P15428 1/20 0.60
ALOX15 P16050 1/20 0.60
TSHR P16473 1/20 0.60
ATM Q13315 1/20 0.60
CHRNB2 P17787 1/20 0.55
CHRNB4 P30926 1/20 0.55
CHRNA3 P32297 1/20 0.55
CHRNA4 P43681 1/20 0.55
FABP3 P05413 1/20 0.51
FABP4 P15090 1/20 0.51
FABP5 Q01469 1/20 0.51
CCR4 P51679 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
FADS1 O60427 1/20 0.46
KDM4E B2RXH2 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353953 1.00 CDC25B (0.60) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL20317136 0.96 CDC25B (0.56) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL24155702 0.92 CDC25B (0.60) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL18655632 0.91 CDC25B (0.51) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL24550973 0.90 ALDH1A1 (0.49) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL26557613 0.88 ALDH1A1 (0.51) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL12476377 0.87 HSD17B10 (0.58) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL30021230 0.87 ALDH1A1 (0.58) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL16623900 0.86 FABP3 (0.56) CDC25BALDH1A1CYP3A4HSD17B10TP53
SCHEMBL16383581 0.84 CDC25B (0.51) CDC25BALDH1A1CYP3A4HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106753701-B Diesel engine lubricating oil composite and preparation method thereof, purposes 中国石油化工股份有限公司 2019-07-23 CN claimed
US-20230200223-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
US-20230200223-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
CN-113387819-B Phenanthrene compound, preparation method and application thereof, and organic electroluminescent device 武汉尚赛光电科技有限公司 2023-05-19 CN disclosed
US-20230124929-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-04-20 US disclosed
CN-113387819-A Phenanthrene compound, preparation method and application thereof, and organic electroluminescent device 武汉尚赛光电科技有限公司 2021-09-14 CN disclosed
US-20210234104-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-07-29 US disclosed
WO-2021136064-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2021-07-08 WO disclosed
WO-2021136006-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2021-07-08 WO disclosed
EP-2087011-B1 TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND OLEFINS USING THE SAME SK INNOVATION CO LTD (KR) 2015-09-16 EP disclosed
US-9115112-B2 Aminoanthracene derivative and an organic electroluminescent element employing the same DOOSAN CORPORATION (KR) 2015-08-25 US disclosed
US-8742043-B2 Transition metal catalytic systems and methods for preparing ethylene homopolymers or copolymers of ethylene and olefins using the same SK INNOVATION CO., LTD. (KR) 2014-06-03 US disclosed
US-20120161615-A1 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME DOOSAN CORPORATION (KR) 2012-06-28 US disclosed
WO-2010147318-A2 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME 주식회사 두산 (KR) 2010-12-23 WO disclosed
US-20100048840-A1 TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND OLEFINS USING THE SAME SK INNOVATION CO., LTD. (KR) 2010-02-25 US disclosed
EP-2087011-A1 TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND OLEFINS USING THE SAME SK Energy Co., Ltd. (KR) 2009-08-12 EP disclosed
WO-2008054117-A1 TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND OLEFINS USING THE SAME SK ENERGY CO., LTD. (KR) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124929-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS EXOC1, RPS10, EXOSC10 CDC25B 4345/4885ALDH1A1 1811/4885CYP3A4 1570/4885
US-20230200223-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE SLC1A2, MAOA, SLC18A1 CDC25B 3579/4885ALDH1A1 8/4885CYP3A4 1762/4885
US-20100048840-A1 TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND OLEFINS USING THE SAME MCM4, ETV6, HMBS CDC25B 2012/4885ALDH1A1 3661/4885CYP3A4 31/4885
US-20120161615-A1 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME AADAT, ALAD, AAAS CDC25B 1315/4885ALDH1A1 277/4885CYP3A4 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.